News and Announcements
QCollect’s Successful First Stage Build
- Published April 06, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- QCollect’s launches first two products
- Partner Delivery product enables major couriers to use QCollect as a first point of delivery strategy
- QCollects technology promotes infinite scale, but minimal cost
QCollect has successfully launched the first two products on it’s temporary storage and collection Platform – Partner Delivery and Consumer Collection.
The Partner Delivery product enables major couriers to use QCollect as a first point of delivery strategy or a failed delivery strategy for existing customers. This reduces operating costs as parcels are no longer stored and managed by the courier.
Consumer Collection focuses on Mums and Dads who are time poor and want to choose QCollect as a first point of delivery. Ordering online from your favourite retailer and choosing to deliver to a handy QCollect lockerbank for pick up 24/7 on a pay as you use basis, makes life easy.
The technology behind the QCollect Platform uses Amazon Web Services (AWS) and the latest in serverless technology, which means infinite scale, but minimal cost. So we can focus on what is important, delivering value to our customers.
About QCollect
QCollect is the handy way to collect, deliver and send parcels. Our technology platform interacts with smart lockers to meet the ever-increasing consumer demand for handy parcel collection and delivery.
The individual locker boxes enable you to store items temporarily and securely; and you can access the locker 24/7.
QCollect’s vision is to be APAC’S leading open network of logistics solutions and the handy link between convenience and life.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
